Halofuginone(RU-19110) - Moligand™, ≥98% , CAS No.55837-20-2

CAS: 55837-20-2 Cat. No.: H413919 Summenformel: C16H17BrClN3O3 Molekulargewicht: 414.68
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
(-)-Halofuginone|7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one.|7-Bromo-6-chlorofebrifunine|rel-7-Bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4(3H)-one
Storage
Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
H413919-5mg
—
7 Auf Lager

9,46€

14,66€
Speichern 5,21 € (35.50%)
25mg
H413919-25mg
—
6 Auf Lager

33,76€

51,11€
Speichern 17,35 € (33.96%)
100mg
H413919-100mg
—
6 Auf Lager

106,65€

160,44€
Speichern 53,80 € (33.53%)
250mg
H413919-250mg
—
2 Auf Lager

181,27€

272,38€
Speichern 91,11 € (33.45%)
Enter a quantity for the sizes you want to add.

Übersicht

Information

Halofuginone Halofuginone (RU-19110) is the competitively inhibitor of prolyl-tRNA synthetase with Ki of 18.3 nM.It could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in mammal.


Targets

Smad3 ; prolyl-tRNA synthetase (Cell-free assay) ; 18.3nM(Ki)


In vitro

In mammals, halofuginone at 10 ng/ml down-regulates Smad3, blocking TGF-β signaling and preventing both the differentiation of fibroblasts to myofibroblasts and the transitioning of epithelial cells to mesenchymal cells.


In vivo

Halofuginone clearly extends the survival times of the parasite-infected mice. Oral treatment with halofuginone at doses of 0.2 and 1 mg/kg has an apparent curative effect for the infected mice.The subcutaneous administration of 0.2 mg of halofuginone per kg likewise extends the survival times of the infected mice, but none of the mice is cured. The mice in the 5-mg/kg dose groups die before the completion of treatment with the drug either orally or subcutaneously. Subcutaneous treatment with halofuginone appears to be more toxic to mice than oral treatment.


Cell Research(from reference)

Cell lines:primary murine CD4+ CD25− T cells/MEFs 

Concentrations:5-20nM 

Incubation Time:4 or 24hrs 

Spezifikationen

Synonyme
(-)-Halofuginone | 7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one. | 7-Bromo-6-chlorofebrifunine | rel-7-Bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4(3H)-one
Spezifikationen & Reinheit
Moligand™, ≥98%
Biochemische und physiologische Mechanismen
Halofuginone (RU-19110) is the competitively inhibitor of prolyl-tRNA synthetase with Ki of 18.3 nM.It could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in mammal.
Storage
Store at -20°C,Argon charged
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
INHIBITOR
Reinheit
≥98%
Produkteigenschaften
ALogP
1.648
hba_count
3
HBD-Zahl
2
Rotationsfähige Bindung
4
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504758636
SMILES
C1CC(C(NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O
IUPAC Name
7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one
InChIKey
LVASCWIMLIKXLA-LSDHHAIUSA-N
InChI
1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m0/s1
Isomere SMILES
C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O
Molekulargewicht
414.68
Reaxys
840969
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=840969&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseDiazanaphthalenes
SubclassBenzodiazines
Intermediate Tree Nodes Not available
Direct ParentQuinazolines
Alternative Parents Pyrimidones  Piperidines  Aryl bromides  Aryl chlorides  Benzenoids  Beta-amino ketones  Heteroaromatic compounds  Secondary alcohols  1,2-aminoalcohols  Lactams  Azacyclic compounds  Dialkylamines  Hydrocarbon derivatives  Organic oxides  Organobromides  Organochlorides  Organopnictogen compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Quinazoline - Pyrimidone - Aryl bromide - Aryl chloride - Aryl halide - Beta-aminoketone - Benzenoid - Pyrimidine - Piperidine - Heteroaromatic compound - 1,2-aminoalcohol - Ketone - Lactam - Secondary alcohol - Secondary aliphatic amine - Azacycle - Secondary amine - Organobromide - Organohalogen compound - Amine - Alcohol - Organic nitrogen compound - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organic oxygen compound - Organochloride - Organonitrogen compound - Organooxygen compound - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as quinazolines. These are compounds containing a quinazoline moiety, which is made up of two fused six-member aromatic rings, a benzene ring and a pyrimidine ring.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

14 results found

Lot NumberCertificate TypeDatumArtikel
J2331063J2331063Certificate of AnalysisAug 04, 2026 H413919
H2513666H2513666Certificate of AnalysisJul 26, 2025 H413919
H2513667H2513667Certificate of AnalysisJul 26, 2025 H413919
H2513668H2513668Certificate of AnalysisJul 26, 2025 H413919
H2513669H2513669Certificate of AnalysisJul 26, 2025 H413919
G2215614G2215614Certificate of AnalysisApr 03, 2025 H413919
G2215615G2215615Certificate of AnalysisApr 03, 2025 H413919
F2428465F2428465Certificate of AnalysisApr 26, 2024 H413919
F2428466F2428466Certificate of AnalysisApr 26, 2024 H413919
F2428467F2428467Certificate of AnalysisApr 26, 2024 H413919
F2428468F2428468Certificate of AnalysisApr 26, 2024 H413919
F2528074F2528074Certificate of AnalysisApr 26, 2024 H413919
G2412322G2412322Certificate of AnalysisApr 26, 2024 H413919
C2426061C2426061Certificate of AnalysisJun 05, 2022 H413919
Chemische und physikalische Eigenschaften
LöslichkeitSolubility (25°C) In vitro DMSO: 8 mg/mL (19.29 mM); Water: Insoluble; Ethanol: Insoluble;
Empfindlichkeitair sensitive
DMSO (mg/ml) Maximale Löslichkeit20
DMSO (mM) Maximale Löslichkeit48.22996045
Wasser (mg/ml) Maximale Löslichkeit<1
Molekulargewicht414.7
XLogP31.400
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass413.014 Da
Monoisotopic Mass413.014 Da
Topological Polar Surface Area82.000 Ų
Heavy Atom Count24
Formal Charge0
Complexity533.000
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
Reaxys
840969
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=840969&ln=
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.